Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele

1. Sandler SG, Roseff SD, Domen RE, Shaz B, Gottschall JL. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists. Arch Pathol Lab Med 2014;138:620–5. Sandler SG Roseff SD Domen RE Shaz B Gottschall JL . Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists . Arch Pathol Lab Med 2014 ; 138 : 620 – 5 . 10.5858/arpa.2013-0141-CP24786120 Search in Google Scholar

2. Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 2015;55:680–9. Sandler SG Flegel WA Westhoff CM It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group . Transfusion 2015 ; 55 : 680 – 9 . 10.1111/trf.12941435754025438646 Search in Google Scholar

3. Flegel WA, Denomme GA, Queenan JT, et al. It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855–9. Flegel WA Denomme GA Queenan JT It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4 . Transfusion 2020 ; 60 : 855 – 9 . 10.1111/trf.15741912135032163599 Search in Google Scholar

4. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93. Wagner FF Gassner C Müller TH Schönitzer D Schunter F Flegel WA . Molecular basis of weak D phenotypes . Blood 1999 ; 93 : 385 – 93 . 10.1182/blood.V93.1.385 Search in Google Scholar

5. Pirelli KJ, Pietz BC, Johnson ST, Pinder HL, Bellissimo DB. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Prenat Diagn 2010;30:1207–12. Pirelli KJ Pietz BC Johnson ST Pinder HL Bellissimo DB . Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D . Prenat Diagn 2010 ; 30 : 1207 – 12 . 10.1002/pd.265221072752 Search in Google Scholar

6. Grootkerk-Tax MG, Maaskant-van Wijk PA, van Drunen J, van der Schoot CE. The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events. Transfusion 2005;45:327–37. Grootkerk-Tax MG Maaskant-van Wijk PA van Drunen J van der Schoot CE . The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events . Transfusion 2005 ; 45 : 327 – 37 . 10.1111/j.1537-2995.2005.04199.x15752149 Search in Google Scholar

7. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662–8. Wagner FF Flegel WA . RHD gene deletion occurred in the Rhesus box . Blood 2000 ; 95 : 3662 – 8 . 10.1182/blood.V95.12.3662.012k12_3662_3668 Search in Google Scholar

8. Wagner FF, Moulds JM, Flegel WA. Genetic mechanisms of Rhesus box variation. Transfusion 2005;45:338–44. Wagner FF Moulds JM Flegel WA . Genetic mechanisms of Rhesus box variation . Transfusion 2005 ; 45 : 338 – 44 . 10.1111/j.1537-2995.2005.04339.x15752150 Search in Google Scholar

9. Wagner FF, Moulds JM, Tounkara A, Kouriba B, Flegel WA. RHD allele distribution in Africans of Mali. BMC Genet 2003;4:14. Wagner FF Moulds JM Tounkara A Kouriba B Flegel WA . RHD allele distribution in Africans of Mali . BMC Genet 2003 ; 4 : 14 . 10.1186/1471-2156-4-1422291214505497 Search in Google Scholar

10. Seltsam A, Wagner FF, Salama A, Flegel WA. Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003;43:1563–6. Seltsam A Wagner FF Salama A Flegel WA . Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study . Transfusion 2003 ; 43 : 1563 – 6 . 10.1046/j.1537-2995.2003.00565.x14617316 Search in Google Scholar

11. Beadling W, Cooling L. Immunohematology. In: McPherson R, Pincus M, Eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, PA: Elsevier, 2007: 617–36. Beadling W Cooling L . Immunohematology . In: McPherson R Pincus M , Eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods . Philadelphia, PA : Elsevier , 2007 : 617 – 36 . Search in Google Scholar

12. Westhoff CM, Nance S, Lomas-Francis C, Keller M, Chou ST. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus 2019;17:91–3. Westhoff CM Nance S Lomas-Francis C Keller M Chou ST . Experience with RHD*weak D type 4.0 in the USA . Blood Transfus 2019 ; 17 : 91 – 3 . Search in Google Scholar

13. Ouchari M, Srivastava K, Romdhane H, Jemni Yacoub S, Flegel WA. Transfusion strategy for weak D type 4.0 based on RHD alleles and RH haplotypes in Tunisia. Transfusion 2018;58:306–12. Ouchari M Srivastava K Romdhane H Jemni Yacoub S Flegel WA . Transfusion strategy for weak D type 4.0 based on RHD alleles and RH haplotypes in Tunisia . Transfusion 2018 ; 58 : 306 – 12 . 10.1111/trf.14411580342929193104 Search in Google Scholar

14. Flegel WA, Peyrard T, Chiaroni J, Tournamille C, Jamet D, Pirenne F. A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes. Blood Transfus 2019;17:89–90. Flegel WA Peyrard T Chiaroni J Tournamille C Jamet D Pirenne F . A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes . Blood Transfus 2019 ; 17 : 89 – 90 . Search in Google Scholar

15. Evans ML, Holmes B, Dowling K, et al. Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti-D in pregnancy. Transfus Med 2021;31:36–42. Evans ML Holmes B Dowling K Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti-D in pregnancy . Transfus Med 2021 ; 31 : 36 – 42 . 10.1111/tme.12743789863133319442 Search in Google Scholar

16. Kacker S, Vassallo R, Keller MA, et al. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion 2015;55:2095–103. Kacker S Vassallo R Keller MA Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype . Transfusion 2015 ; 55 : 2095 – 103 . 10.1111/trf.13074473982325808011 Search in Google Scholar

17. Laget L, Izard C, Durieux-Roussel E, et al. Relevance and costs of RHD genotyping in women with a weak D phenotype. Transfus Clin Biol 2019;26:27–31. Laget L Izard C Durieux-Roussel E Relevance and costs of RHD genotyping in women with a weak D phenotype . Transfus Clin Biol 2019 ; 26 : 27 – 31 . 10.1016/j.tracli.2018.05.00129866395 Search in Google Scholar

18. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol 2006;13:476–83. Flegel WA . How I manage donors and patients with a weak D phenotype . Curr Opin Hematol 2006 ; 13 : 476 – 83 . 10.1097/01.moh.0000245694.70135.c317053462 Search in Google Scholar